BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, January 16, 2026
Breaking News: BioWorld Science 2025 Year in Review
See today's BioWorld Science
Home
» Prime Medicine and Cimeio collaborate to improve HSC transplants for genetic diseases, AML and MDS
To read the full story,
subscribe
or
sign in
.
Immune
Prime Medicine and Cimeio collaborate to improve HSC transplants for genetic diseases, AML and MDS
June 23, 2023
Prime Medicine Inc. and Cimeio Therapeutics Inc. have entered into a research collaboration to combine their respective technologies.
BioWorld Science
Collaboration
Cancer
Genetic/congenital
Immune
